Cellosaurus logo
expasy logo

Cellosaurus SEES3 (CVCL_1Q91)

[Text version]
Cell line name SEES3
Synonyms SEES-3; SEi-iku Embryonic Stem-3
Accession CVCL_1Q91
Resource Identification Initiative To cite this cell line use: SEES3 (RRID:CVCL_1Q91)
Comments From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
Omics: Deep exome analysis.
Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
Cell type: Embryonic stem cell; CL=CL_0002322.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_ZJ89 (SEES3-1L)CVCL_ZJ91 (SEES3-1V)CVCL_ZJ90 (SEES3-3L)
CVCL_ZJ92 (SEES3-5V)
Sex of cell Male
Age at sampling Blastocyst stage
Category Embryonic stem cell
Publications

PubMed=31245438; DOI=10.1016/j.reth.2014.12.004
Akutsu H., Machida M., Kanzaki S., Sugawara T., Ohkura T., Nakamura N., Yamazaki-Inoue M., Miura T., Vemuri M.C., Rao M.S., Miyado K., Umezawa A.
Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells.
Regen. Ther. 1:18-29(2015)

PubMed=31245498; DOI=10.1016/j.reth.2016.06.003
Akutsu H., Nasu M., Morinaga S., Motoyama T., Homma N., Machida M., Yamazaki-Inoue M., Okamura K., Nakabayashi K., Takada S., Nakamura N., Kanzaki S., Hata K., Umezawa A.
In vivo maturation of human embryonic stem cell-derived teratoma over time.
Regen. Ther. 5:31-39(2016)

PubMed=33225099; DOI=10.31662/jmaj.2018-0029
Umezawa A., Sato Y., Kusakawa S., Amagase R., Akutsu H., Nakamura K., Kasahara M., Matsubara Y., Igarashi T.
Research and development strategy for future embryonic stem cell- based therapy in Japan.
JMA J. 3:287-294(2020)

Cross-references
Cell line collections (Providers) RCB; HES0008
Cell line databases/resources SKIP; SKIP001148
Encyclopedic resources Wikidata; Q54952776
Entry history
Entry creation08-Jul-2015
Last entry update29-Jun-2023
Version number9